1. Short title This Act may be cited as the Joe Fiandra Access to Home Infusion Act of 2023 . 2. Medicare coverage of external infusion pumps and non-self-administrable home infusion drugs (a) Clarifying appropriate for use in the home criteria for DME definition Section 1861(n) of the Social Security Act ( 42 U.S.C. 1395x(n) ) is amended by adding at the end the following new sentence: An external infusion pump and associated infusion drug or other associated supplies shall be treated as meeting the appropriate for use in the home requirement applied to the definition of durable medical equipment under section 414.202 of title 42, Code of Federal Regulations (or any successor to such regulation) and shall be covered as durable medical equipment under this title if each of the following criteria (as described in the Notice of Proposed Rulemaking titled Expanded Classification of External Infusion Pumps as Durable Medical Equipment published in the Federal Register on November 4, 2020 (85 Fed. Reg. 70404)) is satisfied: (1) The Food and Drug Administration-required labeling requires the home infusion drug associated with the pump to be prepared immediately prior to administration or administered by a health care professional or both. (2) A qualified home infusion therapy supplier (as defined in subsection (iii)(3)(D)) administers the drug or biological in a safe and effective manner in the patient’s home (as defined in subsection (iii)(3)(B)). (3) The labeling described in paragraph (1) specifies infusion via an external infusion pump as a possible route of administration, at least once per month, for the drug. . (b) Implementation Notwithstanding any other provision of law, any home infusion drug associated with an external infusion pump that satisfies the criteria described in each of paragraphs (1), (2), and (3) of section 1861(n) of the Social Security Act ( 42 U.S.C. 1395x(n) ), as added by subsection (a), shall be included in the Local Coverage Determination on External Infusion Pumps made under title XVIII